Meet the Evotec team and learn about our research at #SLAS2025 in San Diego https://hubs.ly/Q032Zd__0 Dirk Winkler, SVP Hit Identification, will be presenting on AI/ML integration and its value in accelerating drug discovery and improving overall project success. Schedule a meeting with Dirk at booth #850 by contacting info@evotec.com. #HitIdentification #DrugDiscovery #ArtificialIntelligence #MachineLearning
About us
Evotec is a biotechnology company that is committed to advancing drug discovery and development. Through flexible business models, we collaborate with pharmaceutical companies, biotechs, foundations, and government agencies on a substantial scale. We believe that by working together, we can make a difference in the lives of patients. Our Pipeline Co-Creation model represents our adaptable, multi-modality, fully integrated end-to-end approach to drive collaborations and services across all phases of drug discovery and development – from discovery of novel targets to achieving Proof of Concept in the clinic and into commercial manufacturing. We aspire to contribute data-driven disease understanding and early disease relevance in humans to bring the probability of success up. We select the right modality, which is then propelled forward on our platforms by our passionate people striving for the fastest and most effective ways towards patient impact. This is enabled by convergence of human ingenuity with data and AI. We also offer specific solutions, products, and CRO/CDMO-like services, always in support of the Biopharma R&D innovator. Our more than 4,000 scientists work closely with numerous partners concurrently, delivering fully integrated research and development portfolios or individual projects with the highest quality standards and efficiency, coupled with great science, passion, engagement, and communication.
- Website
-
http://www.evotec.com
External link for Evotec
- Industry
- Biotechnology Research
- Company size
- 5,001-10,000 employees
- Headquarters
- Hamburg
- Type
- Public Company
- Specialties
- CNS, Oncology, Pain, Neurosciences, Inflammation, Metabolic disease, Infection, Respiratory diseases, Drug-Discovery, CMC, IND enabling, and Drug Development
Locations
-
Primary
Manfred Eigen Campus
Essener Bogen 7
Hamburg, 22419, DE
Employees at Evotec
Updates
-
Experience the full potential of the Cyprotex e-Store with our demo guide. Dive into a step-by-step tutorial that guides you through all essential features and functionalities, from start to finish. Get started now! https://hubs.ly/Q031sq7F0 #researchneverstops
-
Meet our team and learn about our research at #SLAS2025 in San Diego https://hubs.ly/Q032dcNB0. Mélanie Carquin PhD, Team Leader in Evotec’s HTP Biology & Screening group will be presenting research on RNA splicing modulators and their role in drugging ‘undruggable’ targets. To learn more about our research, schedule a meeting with our experts at booth #850 by contacting info@evotec.com. #hitidentification #undruggabletargets #splicingmodulators #DrugDiscovery
-
Just - Evotec Biologics has taken a significant step towards leveraging AI and ML for biopharmaceutical discovery by creating a Humanoid Antibody Library. In our latest publication, we describe the validation of this library by isolating antibodies against a target of pandemic concern, SARS-CoV-2. We successfully identified a panel of human monoclonal antibodies that are novel, diverse, and pharmacologically active. These first-generation antibodies exhibited neutralization of SARS-CoV-2 viral infectivity across multiple strains and indicated high developability potential. These results demonstrate the applicability of our platform for effective therapeutic antibody discovery. Read more here- https://hubs.ly/Q02SjSzQ0 #MachineLearning #AI #Biopharmaceuticals #Therapeutics #SARSCoV2 #AntibodyDiscovery #JustEvotecBiologics
-
We are thrilled to announce the release of our latest scientific paper: "Real World Applications and Experiences of AI/ML Deployment for Drug Discovery". This work represents a significant milestone in the integration of artificial intelligence (AI) and machine learning (ML) within the field of medicinal chemistry. Key Highlights: - Innovative AI/ML Techniques: We explore the deployment of cutting-edge AI/ML methodologies in drug discovery, from early target identification to lead optimization. - Collaborative Efforts: Our paper showcases the collaborative efforts of our talented team across multiple locations, including the UK, France, Italy, and the US. - Real-World Impact: We discuss the practical applications and challenges of integrating AI/ML in drug discovery, emphasizing the importance of blending human expertise with advanced computational tools. - Future Perspectives: Insights into the future of AI in medicinal chemistry and its potential to revolutionize the drug discovery process. This paper is a testament to our commitment to innovation and excellence in the field. We believe that the integration of AI/ML technologies will continue to drive significant advancements in drug discovery, making treatments more effective and accessible. Read it here- https://hubs.ly/Q032d6-P0 #AI #ML #DrugDiscovery
-
Our J. MD™ Molecular Design service helps derisk CMC efforts by helping biopharma companies select an optimal lead candidate and optimize the molecular design of biologics to ensure manufacturability, stability, and efficacy from the earliest stages of development. How? Read our blog to find out: https://hubs.ly/Q02SFGrD0 Contact us: info@evotec.com #JustEvotecBiologics #ContinuousBiomanufacturing #Developability #Preclinical
-
Our drug discovery experts will be traveling to #SLAS2025 in San Diego this month. Group leader of Evotec's In Vitro Biology department, Kamran Honarnejad, PhD, is chairing a session on Functional Genomics, co-chairing the Omics/Spatial Omics track, and presenting research and case studies on integration of CRISPR screening with high-dimensional readout technologies for target identification and validation. Learn more about our research presented at SLAS2025 here - https://hubs.ly/Q031qtcM0. Schedule a meeting with our experts at booth #850 by contacting info@evotec.com. #SLAS2025 #CRISPR #TargetIdentification #TargetValidation #DrugDiscovery
-
Our Chief Scientific Officer, Cord Dohrmann recently spoke to Reda Guiha, Country President of Pfizer in France, about our multi-year master research collaboration with Pfizer focusing on early discovery research for metabolic and infectious diseases. The research will be carried out at Evotec's state-of-the-art site in France. We are looking forward to the continued collaborating in the new year. To learn more about the partnership, read the full press release here- https://hubs.ly/Q031Jw7G0 #DrugDiscovery #TogetherForMedicinesThatMatter #MetabolicDisease #InfectiousDisease
-
Missed our recent virtual roundtable on "Antibody Design to Support Global Health Initiatives"? No worries! You can now watch the on-demand recording and gain valuable insights from leading experts in the field. Why Watch? - Discover cutting-edge strategies in antibody design. - Learn how these innovations are driving global health initiatives. - Hear from top scientists and industry leaders. Event Highlights: - In-depth discussions on the latest advancements. - Real-world applications and case studies. - Interactive Q&A sessions with the experts. Don't miss out on this opportunity to expand your knowledge and contribute to global health solutions. Click the link below to access the recording: Watch Now- https://hubs.ly/Q031qD9P0 Let's work together to make a difference! #GlobalHealth #AntibodyDesign #Innovation #Healthcare #JustEvotecBiologics
-
Meet Bernhard: Driving Innovation in Software Engineering at Evotec! We’re thrilled to continue our Employee Stories Series with Bernard, a talented software engineer at Evotec who is playing a crucial role in shaping the future of healthcare through technology. Bernhard’s story highlights: 🔹How his software engineering expertise fuels innovation at Evotec 🔹The impact of staying curious and constantly learning in tech 🔹The role of software in advancing healthcare breakthroughs and improving patient outcomes At Evotec, our software engineers like Bernhard are at the heart of transforming how we approach research, collaboration, and medicine. Bernhard’s story is a perfect example of how curiosity, creativity, and coding are paving the way for a healthier future. Watch the first part of Bernard’s story below and discover what #beCUREious means to him. Stay tuned as we share more Employee Stories, highlighting the inspiring journeys and the amazing work happening behind the scenes! Explore more on our website- https://hubs.ly/Q031Fvws0 #beCUREious #ResearchNeverStops #EmployeeExperience #EmployerBranding #HumanResources #innovation #LifeSciences #technology #creativity #Future #SocialMedia